Skip to main content
Tech.euFundingExplorerBeta

Imcheck Therapeutics

Exited

Biotech solutions company

Total raised
€216M
€215,580,000
Funding rounds
4
Investors
11
distinct backers
Active since
2017-05
latest 2022-06

Funding by year

EUR raised per year

Exit

Type
acquisition
Date
Oct 2025
Value
€1.0B
Acquiror
Ipsen (France)